Who We Are Diplomat Fact Sheet
WHO WE ARE DIPLOMAT FACT SHEET ABOUT LOCATIONS • Flint, Michigan • Omaha, Nebraska • Birmingham, Alabama • Brooklyn, New York • Scottsdale, Arizona • Ronkonkoma, New York • Carlsbad, California • West Babylon, New York • Ontario, California • Greensboro, North Carolina • Van Nuys, California • Raleigh, North Carolina • Enfield, Connecticut • Cincinnati, Ohio DIPLOMAT (NYSE: DPLO) SERVES • Fort Lauderdale, Florida • Boothwyn, Pennsylvania patients and physicians in all 50 states. • Chicago, Illinois • Cordova, Tennessee Headquartered in Flint, Michigan, we focus • Urbandale, Iowa • Henderson, Tennessee on medication management programs for • Kansas City, Kansas • Winchester, Tennessee people with complex chronic diseases. • Beltsville, Maryland • Houston, Texas Diplomat is an innovative, patient- • Woburn, Massachusetts • Richardson, Texas focused specialty pharmacy dedicated • Savage, Minnesota • Chantilly, Virginia to providing therapy management and • Columbia, Missouri clinical services to patients nationwide • South Milwaukee, Wisconsin in a caring, supportive environment. PHILOSOPHY “TAKE GOOD CARE OF PATIENTS AND THE REST FALLS INTO PLACE.” —DALE HAGERMAN, DIPLOMAT COFOUNDER TO US, EXCELLENCE MEANS GIVING patients their best chance for happier lives—lives with more moments, more milestones, more memories in the making. The result isn’t just an outcome; it’s an impact. That’s why we commit to helping AT DIPLOMAT, WE BLEND CLINICAL one patient at a time. excellence with a personal touch—for happier lives and health that lasts. BUSINESS CONCENTRATIONS ACCREDITATIONS DIPLOMAT FOCUSES ON SPECIALTY DRUGS THAT DIPLOMAT AND OUR SUBSIDIARIES treat patients with complex chronic diseases and require are accredited or certified by third- specialized handling, distribution, and administration. party agencies committed to industry Diplomat believes in a “one patient at a time” approach that best practices, including Accreditation is a combination of high-touch and robust service offerings.
[Show full text]